PATRIZI, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 188
NA - Nord America 162
AS - Asia 136
SA - Sud America 11
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
Totale 503
Nazione #
US - Stati Uniti d'America 158
IT - Italia 74
CN - Cina 50
SG - Singapore 48
SE - Svezia 41
HK - Hong Kong 27
RU - Federazione Russa 22
DE - Germania 21
BR - Brasile 11
FI - Finlandia 10
NL - Olanda 6
GB - Regno Unito 4
IN - India 4
PH - Filippine 4
CA - Canada 3
IE - Irlanda 3
PT - Portogallo 3
A1 - Anonimo 2
ID - Indonesia 2
TN - Tunisia 2
AT - Austria 1
BE - Belgio 1
DO - Repubblica Dominicana 1
EU - Europa 1
GR - Grecia 1
KE - Kenya 1
LT - Lituania 1
PK - Pakistan 1
Totale 503
Città #
Ashburn 31
Hong Kong 27
Shanghai 27
New York 26
Singapore 22
Milan 15
Boardman 13
Helsinki 9
Lawrence 8
Princeton 8
Nuremberg 6
Amsterdam 5
Moscow 5
Rome 5
Seattle 5
Vittoria 5
Cesano Boscone 4
Dallas 4
Guangzhou 4
Pune 4
Quezon City 4
Washington 4
Angera 3
Brookings 3
Dublin 3
Falkenstein 3
Guarda 3
Romagnano Sesia 3
Bandung 2
Bari 2
Belo Horizonte 2
Bergamo 2
Gatchina 2
Kassel 2
London 2
Manassas 2
Padova 2
Perm 2
Quanzhou 2
Segrate 2
St Petersburg 2
Toronto 2
Torre Del Greco 2
Turin 2
Verona 2
Athens 1
Baoding 1
Borås 1
Brussels 1
Cesano Maderno 1
Changsha 1
Frankfurt am Main 1
Hangzhou 1
Jacobina 1
Lahore 1
Lainate 1
Lappeenranta 1
Macerata 1
Magé 1
Matozinhos 1
Munich 1
Nairobi 1
Nanjing 1
Nizhniy Novgorod 1
North Bergen 1
Nova Serrana 1
Novo Hamburgo 1
Osimo 1
Ottawa 1
Paliano 1
Paraisópolis 1
Pisa 1
San Sperate 1
Santo Domingo 1
Secaucus 1
São Paulo 1
São Sebastião 1
The Dalles 1
União dos Palmares 1
Voronezh 1
Weitang 1
Yangzhou 1
Totale 330
Nome #
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 89
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 58
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 50
Physical and psychological sequelae at three months after acute illness in COVID-19 survivors 44
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 42
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 39
Pruritus characteristics in a large Italian cohort of psoriatic patients 35
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 35
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 33
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 31
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 26
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 23
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study 22
COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study 12
Totale 539
Categoria #
all - tutte 4.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.764


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 3 0 1 1 0 1 0
2021/202233 1 0 0 2 0 6 7 3 6 3 3 2
2022/202394 19 16 4 2 14 10 2 8 5 2 1 11
2023/2024188 7 5 40 11 22 44 9 16 4 2 1 27
2024/2025218 20 8 9 7 29 28 34 38 29 16 0 0
Totale 539